Skip to content

Clinical trials

Phase 2/3 Neurologic Manifestations trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurologic Manifestations Phase: Phase 2/3 Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20191
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Completed2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ProQR Therapeutics2
AO GENERIUM1
Auspex Pharmaceuticals, Inc.1
Icahn School of Medicine at Mount Sinai1
Université de Sherbrooke1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurologic Manifestations6
Nervous System Diseases3
Blindness2
Central Nervous System Diseases2
Dyskinesias2
Eye Abnormalities2
Eye Diseases2
Leber Congenital Amaurosis2
Mental Disorders2
Movement Disorders2

Trials

Showing 26 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.